ES2073425T3 - Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina. - Google Patents

Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina.

Info

Publication number
ES2073425T3
ES2073425T3 ES89123963T ES89123963T ES2073425T3 ES 2073425 T3 ES2073425 T3 ES 2073425T3 ES 89123963 T ES89123963 T ES 89123963T ES 89123963 T ES89123963 T ES 89123963T ES 2073425 T3 ES2073425 T3 ES 2073425T3
Authority
ES
Spain
Prior art keywords
urine
thrombomodulin
type susceptible
new glycoprotein
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89123963T
Other languages
English (en)
Inventor
Yasuyuki Kunihiro
Ryo Tanaka
Michio Ichimura
Akio Uemura
Nobuo Ohzawa
Ei Mochida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2073425T3 publication Critical patent/ES2073425T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTE INVENTO SE REFIERE A UNA NUEVA SUSTANCIA ANTICOAGULANTE PRESENTE EN LA ORINA HUMANA, UN PROCESO PARA SU PREPARACION Y UNA COMPOSICION FARMACEUTICA COMPRENDIENDO DICHA SUSTANCIA PARA LA PREVENCION Y/O TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON DESORDENES EN EL SISTEMA DE COAGULACION DE LA SANGRE
ES89123963T 1988-12-27 1989-12-27 Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina. Expired - Lifetime ES2073425T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33041388 1988-12-27
JP28524089 1989-11-01

Publications (1)

Publication Number Publication Date
ES2073425T3 true ES2073425T3 (es) 1995-08-16

Family

ID=26555801

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89123963T Expired - Lifetime ES2073425T3 (es) 1988-12-27 1989-12-27 Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina.

Country Status (8)

Country Link
US (2) US5202421A (es)
EP (2) EP0632055B1 (es)
AT (2) ATE121100T1 (es)
AU (2) AU626365B2 (es)
CA (1) CA2006658C (es)
DE (2) DE68929388T2 (es)
ES (1) ES2073425T3 (es)
GR (1) GR3015765T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
AU643306B2 (en) * 1990-06-27 1993-11-11 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
JP3537440B2 (ja) * 1993-12-17 2004-06-14 持田製薬株式会社 可溶性トロンボモジュリンを長期保存安定化させる方法
US5981716A (en) * 1995-06-07 1999-11-09 Gruppo Lepettit, S.P.A. Process for the purification of proteins
DE69627191T2 (de) * 1995-06-09 2004-01-08 The Regents Of The University Of Michigan, Ann Arbor Bradikininanaloge als selektive thrombininhibitoren
JP3745805B2 (ja) * 1995-10-24 2006-02-15 日本ケミカルリサーチ株式会社 トロンボモジュリンの精製方法
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
KR100373480B1 (ko) * 1997-10-15 2003-02-25 아사히 가세이 가부시키가이샤 트롬보모듈린 수용액 주사제의 저장 및 유통시의 품질유지 방법
DE19749197A1 (de) * 1997-11-07 1999-05-12 Dade Behring Marburg Gmbh Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
DE19945351C2 (de) * 1999-09-22 2002-04-18 Lohmann Therapie Syst Lts Verfahren zum Auffinden und zur Isolierung pharmakologisch wirksamer Verbindungen aus Substanzgemischen
CN1352087A (zh) * 2000-11-02 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
BR0310087A (pt) * 2002-05-17 2005-08-16 Wyeth Corp Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
JP5579385B2 (ja) * 2006-10-06 2014-08-27 旭化成ファーマ株式会社 播種性血管内血液凝固症候群の治療及び／又は改善剤
ES2496596T3 (es) 2007-03-23 2014-09-19 Asahi Kasei Pharma Corporation Método para producir trombomodulina soluble de gran pureza
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および／または治療剤
SG10201500036WA (en) 2010-04-30 2015-02-27 Asahi Kasei Pharma Corp Highly-purified soluble thrombomodulin and method for producing same
BR112014011488B1 (pt) 2011-11-15 2022-07-05 Asahi Kasei Pharma Corporation Medicamento para tratamento terapêutico e/ou melhora de sépsis
BR112021007460A2 (pt) 2018-10-22 2021-11-03 Asahi Kasei Pharma Corp Medicamento para tratamento terapêutico e/ou melhora de um paciente com sepse

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4810232B1 (es) * 1970-09-04 1973-04-02
BE791783A (fr) * 1972-11-23 1973-05-23 Lilly Co Eli Polypeptides et procede pour les preparer
JPS60199819A (ja) * 1984-03-23 1985-10-09 Kowa Co トロンビン結合性物質およびその製法
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
JPS6330423A (ja) * 1986-07-22 1988-02-09 Kowa Co トロンビン結合性物質およびその製法
US5047503A (en) * 1986-07-15 1991-09-10 Kowa Company, Ltd. Thrombin-binding substance and process for its preparation
JPH0764878B2 (ja) * 1986-10-14 1995-07-12 興和株式会社 抗血液凝固物質及びその製法
EP0816495A1 (en) * 1987-01-08 1998-01-07 Asahi Kasei Kogyo Kabushiki Kaisha DNA coding for a peptide promoting the activation of protein C by thrombin and dprocess for producing the same
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
JPH0219399A (ja) * 1988-07-05 1990-01-23 Oklahoma Medical Res Found トロンビン結合ポリピペプチド
JPH0720997B2 (ja) * 1988-08-29 1995-03-08 興和株式会社 新規なトロンビン結合性物質及びその製法
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof

Also Published As

Publication number Publication date
AU4727889A (en) 1990-08-16
CA2006658A1 (en) 1990-06-27
DE68929388T2 (de) 2002-11-14
ATE121100T1 (de) 1995-04-15
US5202421A (en) 1993-04-13
EP0376251A2 (en) 1990-07-04
ATE215967T1 (de) 2002-04-15
DE68922202D1 (de) 1995-05-18
EP0376251B1 (en) 1995-04-12
AU626365B2 (en) 1992-07-30
DE68922202T2 (de) 1995-09-21
AU653269B2 (en) 1994-09-22
CA2006658C (en) 2000-03-28
EP0632055B1 (en) 2002-04-10
DE68929388D1 (de) 2002-05-16
US5300490A (en) 1994-04-05
EP0632055A1 (en) 1995-01-04
GR3015765T3 (en) 1995-07-31
EP0376251A3 (en) 1990-12-19
AU2742892A (en) 1993-01-07

Similar Documents

Publication Publication Date Title
ES2073425T3 (es) Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina.
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
FI952169A7 (fi) Stabiili valmiste veren koagulaatiohäiriöiden hoitamiseksi
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3685853D1 (de) Mittel zur behandlung von knochenkrankheiten.
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
ATE302944T1 (de) Verfahren zum screening von arzneizubereitungen
DK83889A (da) Anvendelse af laegemiddel til hindring af intraventrikulaer bloedning hos for tidligt foedte boern
FI913818A0 (fi) Nytt trombolytiskt aemne.
DE3481057D1 (de) 2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
HUP9901161A2 (hu) Módosított aktivitású hibrid VIII. faktor
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
RU96117545A (ru) Способ лечения диабетической ретинопатии
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
DE59000311D1 (de) Verwendung von suramin und physiologisch vertraeglichen derivaten davon, gegebenenfalls in kombination mit anti-androgenen mitteln zur herstellung von arzneimitteln zur behandlung des humanen prostatakarzinoms.
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
ATE49599T1 (de) 2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 376251

Country of ref document: ES